The global Neurodiagnostics market is expected to grow from $xx Mn in 2019 to $xx Mn in 2027, at a CAGR of xx% during the forecast period.
Market Overview:
Neurodiagnostics is an allied field of the healthcare profession, which records, monitors, and analyzes the function of the nervous system. The analysis is done by recording electrical activity arising from the brain, spinal cord, peripheral nerves, and motor nerves using a variety of techniques and instruments. According to Global Burden of Disease (GBD)/Institute for Health Metrics and Evaluation, globally in the year 2016, neurological disorders were the leading cause of disability-adjusted life year (DALY) (approximately 276 million) and second the leading cause of deaths (approximately 9 million). Moreover, The World Health Organization (WHO), estimated that the number of patients with neurological diseases will rise from 95 million in the year 2015 to 103 million by the year 2030.
The report covers the detailed analysis of the global Neurodiagnostics industry with the classifications of the market on the product type, condition, and end-users. Analysis of past market dynamics from 2016 to 2019 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key player’s contribution in it.
The report has profiled seventeen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost of treatment, availability of advanced technology are analyzed and the report has come up with recommendations for a future hot spot in APAC region.
Market Dynamics:
The increasing prevalence of neurological disorders and increasing demand for newer therapy options are fueling the growth of the global Neurodiagnostics market. Technological advancements in the field of Neurodiagnostics due to the use of Artificial Intelligence in imaging systems. Growing awareness, high investment in Research & Development field and an increasing number of diagnostics and imaging centers are also driving the market growth. However, high cost and lack of regular checkups in developing economies are hampering the market growth.
Regional Insights:
Global Neurodiagnostics Market1
North America held the largest market share of xx% in 2018. Also, it is expected to continue the dominance throughout the forecast period due to the high prevalence of improved healthcare facilities and the easy availability of advanced tools. According to Centers for Disease Control and Prevention (CDC), in the year 2014, about 5 million Americans were suffering from Alzheimer’s disease and this number is projected to be 14 million people by the year 2060. Europe holds the second largest market share owing to the rising prevalence of neurological disorders due to the aging population.
for more info:https://www.maximizemarketresearch.com/market-report/global-neurodiagnostics-market/82854/
Market Segmentation:
By Product Type:
• Clinical Testing Instruments • Diagnostics and Imaging System
• Reagents and Consumables
By Condition:
• Neurodegenerative Disorders • Epilepsy • Sleep disorder
• Stroke
By End-Users:
• Hospitals and Clinics • Diagnostic laboratories and Imaging centers
• Others
Global Neurodiagnostics Market
Segment Analysis:
The Diagnostics laboratories and Imaging System segment held the largest market share of xx% in 2018 owing to the launch of new technological instruments. This segment is further divided into MRI systems, EEG systems, CT scanners, PET scanners, etc. And new emerging tools due to which is expected to fuel the market share.
Key players operating in Global Neurodiagnostics Market:
• Siemens Healthineers • Thermo Fischer Scientific • Hitachi • Koninklijke Philips • GE healthcare • Neuro Diagnostics Devices • Lifelines Neurodiagnostics systems • Zynex NeuroDiagnostics • Digital NeuroDiagnostics • Ridge Diagnostics • Bio-Rad Laboratories • F-Hoffmann La-Roche AG • Mitsar Co. Ltd. • Nihon Kohden Corporation • QIAGEN N.V.
• Natus Medical Incorporated
The report also helps in understanding Global Neurodiagnostics Market dynamics, structure by analyzing the market segments and project the Global Neurodiagnostics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Neurodiagnostics Market make the report investor’s guide.
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors